patidegib gel
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for patidegib gel, covering 2019-01-04 to 2019-01-04. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas [Phase 2]